Effective "activated PI3Kδ syndrome"-targeted therapy with the PI3Kδ inhibitor leniolisib.
Blood
Rao, V Koneti VK; Webster, Sharon S; Dalm, Virgil A S H VASH; Šedivá, Anna A; van Hagen, P Martin PM; Holland, Steven S; Rosenzweig, Sergio D SD; Christ, Andreas D AD; Sloth, Birgitte B; Cabanski, Maciej M; Joshi, Aniket D AD; de Buck, Stefan S; Doucet, Julie J; Guerini, Danilo D; Kalis, Christoph C; Pylvaenaeinen, Ilona I; Soldermann, Nicolas N; Kashyap, Anuj A; Uzel, Gulbu G; Lenardo, Michael J MJ; Patel, Dhavalkumar D DD; Lucas, Carrie L CL; Burkhart, Christoph C